首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1828156

2025年全球灌注系統市場報告

Perfusion Systems Global Market Report 2025

出版日期: 2025年09月11日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

近年來，灌注系統市場經歷了強勁成長，市場規模從2024年的13.3億美元成長到2025年的14.5億美元，複合年成長率為9.1%。這段歷史時期的成長歸功於灌注科學的基礎研究、低溫技術的引入、心肺體外迴圈的出現、體外循環的早期發展。

預計未來幾年灌注系統市場規模將快速成長，到2029年將達到21.5億美元，複合年成長率為10.4%。預測期內的成長動力包括：對患者預後的關注度不斷提高、心血管手術數量增加、微創手術的擴展、體外膜氧合（ECMO）的使用率不斷提高、全球醫療基礎設施建設以及老年人口的成長。預測期內的主要趨勢包括：可攜式和緊湊型設計、自動化和機器人技術的整合、遠端監控和遠端醫療、模組化和可自訂平台、高級數據分析以及人工智慧。

灌注系統是重要的醫療設備，用於在需要心臟暫時停止運作的外科手術過程中維持患者的血液循環和氧氣供應。它們主要用於需要臨時器官支持的心血管手術和器官移植，並在維持生理穩定性方面發揮至關重要的作用。

心肺灌注系統種類繁多，包括心肺灌注系統、體外膜肺氧合 (ECMO)、離體器官灌注系統以及各種特殊類型的系統。心肺灌注系統可暫時取代心臟和肺的功能，尤其是在心血管手術期間。這些系統可容納各種器官，包括心臟、肺、腎臟和肝臟，並使用低溫和恆溫等技術。其應用範圍涵蓋各種醫療保健機構，包括醫院、診所、門診手術中心和其他各種醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供灌注系統市場統計數據，包括全球灌注系統行業規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的灌注系統細分市場、市場趨勢和商機，以及您在灌注系統行業取得成功所需的數據。本灌注系統市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長10.4%，較先前預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。這種影響將直接影響美國，導致主要從英國和丹麥進口的熱交換器和血氣監測感測器成本上升，並可能影響器官移植和心血管手術的結果。由於互惠關稅以及不斷升級的貿易緊張局勢和限制對全球經濟和貿易造成的負面影響，這種影響也將更加廣泛。

器官移植的快速成長是灌注系統市場預期成長的關鍵驅動力。器官移植是指透過手術將患病或受損的器官從捐贈者轉移到面臨器官衰竭或疾病的接受者。灌注系統在這過程中發揮著至關重要的作用，它能夠保存和運輸器官，並確保其在移植過程中的活力。值得注意的是，美國器官採購和移植網路 (ORTPN) 2021 年 1 月的數據顯示，美國器官移植數量年增 5.9%，達到 41,354 例。這一成長證實了對成功器官移植的需求不斷成長，從而推動了灌注系統市場的發展。

預計未來幾年老齡化人口的成長將成為灌注系統市場擴張的驅動力。老齡化社會的特徵是 65 歲及以上人口比例不斷增加，這通常與可導致器官衰竭的老齡化相關疾病的增加有關。灌注系統在器官移植中起著至關重要的作用，它負責保存器官並將其從捐贈者運送到接受者。這些系統旨在維持人類體外的器官活力，進而增加移植成功的機會。例如，負責全球公共衛生的聯合國專門機構世界衛生組織 (WHO) 預測，到 2030 年，世界上大約六分之一的人將年滿 60 歲或以上。此外，預計到 2050 年，全球 60 歲或以上人口將加倍，達到 21 億。因此，老化人口的成長正在推動灌注系統市場的成長。

產品創新是灌注系統市場的一大趨勢。新興市場先鋒企業正專注於開發創新解決方案，以鞏固其市場地位。 LivaNova 於 2023 年 2 月在歐洲推出的 Essenz 灌注系統就是一個例子。該系統以其緊湊、模組化和可攜式的設計而聞名，是一款專為心血管手術心肺體外迴圈(CPB) 系統。其模組化設計使其能夠根據不同的患者需求和手術程序進行客製化，使其在臨床環境中具有高度的通用性。

灌注系統市場的主要企業正致力於開發創新產品，以提高臨床效率和患者照護，特別是在心肺體外迴圈(CPB) 手術期間。一個顯著的例子是 Essenz 患者監護儀，它具有中央顯示螢幕，永續顯示關鍵患者參數，從而實現量身定做的管理策略。 2022 年 4 月，英國醫療技術創新者 LivaNova PLC 宣布 Essenz 患者監視器獲得監管部門核准並有針對性地進行商業發布。這種先進的監護系統採用以患者為中心的方法，以提高 CPB 手術期間的臨床效率和護理品質。它獲得了美國食品藥物管理局(FDA) 的 510(k) 許可和 CE 標誌，並已在參與以用戶為中心的設計計劃的美國和歐洲部分醫院首次推出。 Essenz 患者監視器增強了負責人在整個 CPB 手術過程中的決策能力，並且與 LivaNova S5 體外循環機完全相容。這項技術創新反映了透過先進的監護技術改善心血管手術結果的更廣泛趨勢。

2022年12月，美國知名製藥公司默克公司（Merck & Co. Inc.）完成了對Erbi Biosystems的收購，收購金額未揭露。此次策略性收購旨在加速開發可擴展的細胞灌註生物反應器工藝，起始工藝最低可達2毫升。此次收購將顯著增強默克在治療性蛋白質領域的上游產品組合。製程解決方案業務部與生命科學服務部共同構成默克「三大」業務驅動力，佔據著舉足輕重的地位。 Erbi Biosystems的整合符合默克致力於推動該業務部創新的承諾。 Erbi Biosystems是一家總部位於美國的生技工具公司。

灌注系統市場的主要企業包括 Getinge AB、Medtronic plc、LivaNova PLC、Terumo Corporation、Lifeline Scientific Inc.、XVIVO Perfusion AB、Repligen Corporation、Spectrum Laboratories Inc.、Merck KGaA、Harvard Bioscience Inc.、 ScientificGE Instruments Inc. COMPANY、Organ Assist Products BV、Hitachi, Ltd.、Bioptechs Inc.、Cytiva Company、Sorin Group、Organ Recovery Systems Inc.、TransMedics Inc.、Paragonix Technologies Inc.、Bridge to Life (Europe) Ltd.、OrganOx Limited 和 Preservation Solutions Inc.

2024 年，北美是灌注系統市場中最大的地區。灌注系統市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

灌注系統市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

灌注系統市場由提供器官移植服務、血液管理服務、細胞分離護理以及心臟和呼吸外科手術服務的營業單位所獲得的收益所構成。市場價值包括服務提供者銷售或包含在其服務產品中的相關商品的價值。灌注系統市場還包括用於提供灌注系統相關服務的氧合器、管道和過濾設備的銷售。該市場的價值為“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

全球灌注系統：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
最終用途產業分析
全球灌注系統市場：成長率分析
全球灌注系統市場表現：規模與成長，2019-2024
全球灌注系統市場預測：規模與成長，2024-2029年，2034年
全球灌注系統：總目標市場（TAM）

第6章市場細分

全球灌注系統市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
心肺灌注系統
體外膜氧合（ECMO）
獨立器官灌注系統
其他產品
全球灌注系統市場（依器官類型）：2019-2024 年、2024-2029 年、2034 年表現及預測
心
肺
腎
肝
其他器官類型
全球灌注系統市場技術、效能及預測（2019-2024、2024-2029、2034）
低溫
正常體溫
全球灌注系統市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
醫院
診所
門診手術中心
其他最終用戶
全球灌注系統市場：心肺灌注系統的細分（按類型）、表現和預測，2019-2024 年、2024-2029 年、2034 年
心肺機
血泵
氧合設備
全球灌注系統市場：按體外膜氧合 (ECMO) 細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
靜脈-動脈 (VA) ECMO 系統
靜脈-靜脈 (VV) ECMO 系統
可攜式ECMO系統
全球灌注系統市場：獨立器官灌注系統的細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
肝臟灌注系統
腎臟灌注系統
心臟灌注系統
全球灌注系統市場：按產品類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
血管插管
熱交換器
灌注監測系統

第7章區域和國家分析

全球灌注系統市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
全球灌注系統市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

灌注系統市場：競爭格局
灌注系統市場：公司簡介
- Getinge AB Overview, Products and Services, Strategy and Financial Analysis
- Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
- Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
- Lifeline Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

XVIVO Perfusion AB
Repligen Corporation
Spectrum Laboratories Inc.
Merck KGaA
Harvard Bioscience Inc.
ALA Scientific Instruments Inc.
XENIOS AG
Siemens Healthcare Private Limited
Shimadzu Corporation
GENERAL ELECTRIC COMPANY
Organ Assist Products BV
Hitachi Ltd.
Bioptechs Inc.
Cytiva Company
Sorin Group

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029年灌注系統市場：提供新機會的國家
2029年灌注系統市場：細分市場帶來新機會
2029年灌注系統市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r24402u

Perfusion systems encompass vital medical devices employed to sustain blood circulation and oxygenation in patients during surgical procedures necessitating a temporary pause in the heart's normal function. Primarily utilized in cardiac surgeries, organ transplants, and other procedures requiring temporary organ function support, these systems play a critical role in maintaining physiological stability.

They come in various types, including cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and specialized variations. Cardiopulmonary perfusion systems specifically substitute the heart and lung functions temporarily during cardiac surgeries. These systems cater to diverse organs such as the heart, lungs, kidneys, liver, and others, employing techniques such as hypothermic and normothermic approaches. Their applications span across different healthcare settings, including hospitals, clinics, ambulatory surgical centers, and various other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The perfusion systems market research report is one of a series of new reports from The Business Research Company that provides perfusion systems market statistics, including perfusion systems industry global market size, regional shares, competitors with a perfusion systems market share, detailed perfusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion systems industry. This perfusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The perfusion systems market size has grown strongly in recent years. It will grow from $1.33 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to the foundational research in perfusion science, the introduction of hypothermia techniques, the inception of cardiopulmonary bypass, and early heart-lung machine development.

The perfusion systems market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to a focus on patient outcomes, a rise in cardiovascular surgeries, expansion of minimally invasive procedures, increased ECMO usage, global healthcare infrastructure development, and growing geriatric population. Major trends in the forecast period include portable and compact designs, automation and robotics integration, remote monitoring and telemedicine, modular and customizable platforms, advanced data analytics, and AI.

The forecast of 10.4% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for heat exchanger units and blood gas monitoring sensors, largely imported from the UK and Denmark, affecting organ transplant and cardiac surgery outcomes.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in organ transplants stands as a significant driving force behind the anticipated growth of the perfusion systems market. Organ transplants involve the surgical transfer of diseased or damaged organs from donors to recipients facing organ failure or disease. Perfusion systems play a vital role in this process by preserving and transporting organs, ensuring their viability during transplantation. Notably, data from the Organ Procurement and Transplantation Network in January 2021 indicated a 5.9% increase in organ transplants in the US, totaling 41,354 procedures, compared to the previous year. This uptick underscores the escalating demand driving the perfusion systems market due to the rising need for successful organ transplants.

The growing aging population is anticipated to drive the expansion of the perfusion systems market in the coming years. An aging population is characterized by a larger percentage of individuals aged 65 and older, which often correlates with a rise in age-related diseases that can lead to organ failure. Perfusion systems play a crucial role in organ transplantation by preserving and transporting organs from donors to recipients. These systems are designed to maintain organ viability outside the human body, thereby enhancing the likelihood of successful transplants. For example, the World Health Organization, a specialized agency of the United Nations focused on global public health, projects that by 2030, approximately 1 in 6 people worldwide will be 60 years or older. Additionally, the global population of individuals aged 60 and above is expected to double to 2.1 billion by 2050. Consequently, the increasing aging population is propelling the growth of the perfusion systems market.

Product innovation emerges as a prominent trend within the perfusion systems market. Leading market players are channeling efforts into developing innovative solutions to fortify their market positions. An instance is LivaNova's February 2023 launch of the Essenz perfusion system in Europe. This system, known for its compact, modular, and portable design, is a cardiopulmonary bypass (CPB) system tailored for cardiac surgeries. Its modularity allows customization for diverse patient needs and surgical procedures, facilitating its versatility across clinical settings.

Major companies in the perfusion systems market are focusing on developing innovative products to enhance clinical efficiency and patient care, particularly during cardiopulmonary bypass (CPB) procedures. A notable example is the Essenz Patient Monitor, which features a centralized display that continuously shows critical patient parameters, enabling tailored management strategies. In April 2022, LivaNova PLC, a UK-based medical technology and innovation company, announced the regulatory approvals and targeted commercial launch of the Essenz Patient Monitor. This advanced monitoring system adopts a patient-centered approach to improve clinical efficiency and care quality during CPB procedures. It received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark, leading to its initial launch in select hospitals across the U.S. and Europe that participated in the user-centric design program. The Essenz Patient Monitor enhances decision-making for perfusionists throughout the CPB procedure and is fully compatible with the LivaNova S5 heart-lung machine. Such innovations reflect a broader trend toward improving outcomes in cardiac surgeries through advanced monitoring technologies.

In December 2022, Merck & Co Inc., a prominent US-based pharmaceutical company, finalized the acquisition of Erbi Biosystems Inc. for an undisclosed sum. This strategic acquisition aims to facilitate the development of scalable cell-based perfusion bioreactor processes, initiating from as little as 2 ml. This move significantly strengthens Merck's upstream portfolio concerning therapeutic proteins. Among Merck's key growth drivers-referred to as its "Big 3," alongside the Life Science Services business unit, the Process Solutions business unit holds pivotal significance. The integration of Erbi Biosystems aligns with Merck's commitment to driving innovation within this specific business unit. Notably, Erbi Biosystems Inc. is a biotechnology tools company based in the United States.

Major companies operating in the perfusion systems market include Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Lifeline Scientific Inc., XVIVO Perfusion AB, Repligen Corporation, Spectrum Laboratories Inc., Merck KGaA, Harvard Bioscience Inc., ALA Scientific Instruments Inc., XENIOS AG, Siemens Healthcare Private Limited Shimadzu Corporation, GENERAL ELECTRIC COMPANY, Organ Assist Products B.V., Hitachi Ltd., Bioptechs Inc., Cytiva Company, Sorin Group, Organ Recovery Systems Inc., TransMedics Inc., Paragonix Technologies Inc., Bridge to Life (Europe) Ltd., OrganOx Limited, Preservation Solutions Inc.

North America was the largest region in the perfusion systems market in 2024. The regions covered in the perfusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the perfusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The perfusion systems market consists of revenues earned by entities by providing organ transplantation service, blood management services, cell isolation care, cardiac and respiratory disorders surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion systems market also includes sales of oxygenators, tubing, and filters equipment which are used in providing perfusion systems related services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Perfusion Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on perfusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for perfusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The perfusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Cardiopulmonary Perfusion System; Extracorporeal membrane oxygenation (ECMO); Isolated Organ Perfusion Systems; Other Products
2) By Type Of Organ: Heart; Lung; Kidney; Liver; Other Type Of Organs
3) By Technique: Hypothermic; Normothermic
4) By End-User: Hospital; Clinic; Ambulatory Surgical Centers; Other End-users
Subsegments:
1) By Cardiopulmonary Perfusion System: Heart-Lung Machines; Blood Pumps; Oxygenators
2) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Arterial (VA) ECMO Systems; Veno-Venous (VV) ECMO Systems; Portable ECMO Systems
3) By Isolated Organ Perfusion Systems: Liver Perfusion Systems; Kidney Perfusion Systems; Heart Perfusion Systems
4) By Other Products: Vascular Cannulae; Heat Exchangers; Perfusion Monitoring Systems
Companies Mentioned: Getinge AB; Medtronic plc; LivaNova PLC; Terumo Corporation; Lifeline Scientific Inc.; XVIVO Perfusion AB; Repligen Corporation; Spectrum Laboratories Inc.; Merck KGaA; Harvard Bioscience Inc.; ALA Scientific Instruments Inc.; XENIOS AG; Siemens Healthcare Private Limited Shimadzu Corporation; GENERAL ELECTRIC COMPANY; Organ Assist Products B.V.; Hitachi Ltd.; Bioptechs Inc.; Cytiva Company; Sorin Group; Organ Recovery Systems Inc.; TransMedics Inc.; Paragonix Technologies Inc.; Bridge to Life (Europe) Ltd.; OrganOx Limited; Preservation Solutions Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Perfusion Systems Market Characteristics

3. Perfusion Systems Market Trends And Strategies

4. Perfusion Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Perfusion Systems Growth Analysis And Strategic Analysis Framework

5.1. Global Perfusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Perfusion Systems Market Growth Rate Analysis
5.4. Global Perfusion Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Perfusion Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Perfusion Systems Total Addressable Market (TAM)

6. Perfusion Systems Market Segmentation

6.1. Global Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiopulmonary Perfusion System
Extracorporeal membrane oxygenation (ECMO)
Isolated Organ Perfusion Systems
Other Products
6.2. Global Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heart
Lung
Kidney
Liver
Other Type Of Organs
6.3. Global Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypothermic
Normothermic
6.4. Global Perfusion Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinic
Ambulatory Surgical Centers
Other End-users
6.5. Global Perfusion Systems Market, Sub-Segmentation Of Cardiopulmonary Perfusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heart-Lung Machines
Blood Pumps
Oxygenators
6.6. Global Perfusion Systems Market, Sub-Segmentation Of Extracorporeal Membrane Oxygenation (ECMO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veno-Arterial (VA) ECMO Systems
Veno-Venous (VV) ECMO Systems
Portable ECMO Systems
6.7. Global Perfusion Systems Market, Sub-Segmentation Of Isolated Organ Perfusion Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liver Perfusion Systems
Kidney Perfusion Systems
Heart Perfusion Systems
6.8. Global Perfusion Systems Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vascular Cannulae
Heat Exchangers
Perfusion Monitoring Systems

7. Perfusion Systems Market Regional And Country Analysis

7.1. Global Perfusion Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Perfusion Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Perfusion Systems Market

8.1. Asia-Pacific Perfusion Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Perfusion Systems Market

9.1. China Perfusion Systems Market Overview
9.2. China Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Perfusion Systems Market

10.1. India Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Perfusion Systems Market

11.1. Japan Perfusion Systems Market Overview
11.2. Japan Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Perfusion Systems Market

12.1. Australia Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Perfusion Systems Market

13.1. Indonesia Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Perfusion Systems Market

14.1. South Korea Perfusion Systems Market Overview
14.2. South Korea Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Perfusion Systems Market

15.1. Western Europe Perfusion Systems Market Overview
15.2. Western Europe Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Perfusion Systems Market

16.1. UK Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Perfusion Systems Market

17.1. Germany Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Perfusion Systems Market

18.1. France Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Perfusion Systems Market

19.1. Italy Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Perfusion Systems Market

20.1. Spain Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Perfusion Systems Market

21.1. Eastern Europe Perfusion Systems Market Overview
21.2. Eastern Europe Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Perfusion Systems Market

22.1. Russia Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Perfusion Systems Market

23.1. North America Perfusion Systems Market Overview
23.2. North America Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Perfusion Systems Market

24.1. USA Perfusion Systems Market Overview
24.2. USA Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Perfusion Systems Market

25.1. Canada Perfusion Systems Market Overview
25.2. Canada Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Perfusion Systems Market

26.1. South America Perfusion Systems Market Overview
26.2. South America Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Perfusion Systems Market

27.1. Brazil Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Perfusion Systems Market

28.1. Middle East Perfusion Systems Market Overview
28.2. Middle East Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Perfusion Systems Market

29.1. Africa Perfusion Systems Market Overview
29.2. Africa Perfusion Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Perfusion Systems Market, Segmentation By Type Of Organ, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Perfusion Systems Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Perfusion Systems Market Competitive Landscape And Company Profiles

30.1. Perfusion Systems Market Competitive Landscape
30.2. Perfusion Systems Market Company Profiles
- 30.2.1. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Lifeline Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Perfusion Systems Market Other Major And Innovative Companies

31.1. XVIVO Perfusion AB
31.2. Repligen Corporation
31.3. Spectrum Laboratories Inc.
31.4. Merck KGaA
31.5. Harvard Bioscience Inc.
31.6. ALA Scientific Instruments Inc.
31.7. XENIOS AG
31.8. Siemens Healthcare Private Limited
31.9. Shimadzu Corporation
31.10. GENERAL ELECTRIC COMPANY
31.11. Organ Assist Products B.V.
31.12. Hitachi Ltd.
31.13. Bioptechs Inc.
31.14. Cytiva Company
31.15. Sorin Group

32. Global Perfusion Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Perfusion Systems Market

34. Recent Developments In The Perfusion Systems Market

35. Perfusion Systems Market High Potential Countries, Segments and Strategies

35.1 Perfusion Systems Market In 2029 - Countries Offering Most New Opportunities
35.2 Perfusion Systems Market In 2029 - Segments Offering Most New Opportunities
35.3 Perfusion Systems Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies